/study / lectures / Pre-anesthesia
Preop Anemia Optimization + Patient Blood Management + Jehovah's Witness Plan
TEXTPre-anesthesia · 7 min read
Preoperative anemia doubles surgical mortality + drives most transfusions. Patient blood management (PBM) is the formal program; the Jehovah's Witness plan is the extreme case that teaches the principles.
After this lesson you can
3 min read6 sectionsPrevalence + impact of preop anemia
Anemia independently doubles 30-day mortality, increases LOS, increases readmission, and is the strongest predictor of allogeneic transfusion — which itself carries TRALI, TACO, immunomodulation, infection, and acute hemolytic reaction risk.
Preop optimization is a high-yield intervention with class IA evidence in cardiac + orthopedic surgery (Munoz Anesthesia 2017 International Consensus).

Workup of preop anemia
30 ng/mL = absolute iron deficiency; ferritin 30-100 with TSAT <20% = functional iron deficiency (often inflammation-related).B12 + folate (macrocytic).
Reticulocyte count (response).
Hemolysis labs (haptoglobin, LDH, indirect bilirubin) if hemolysis suspected.
CKD: EPO often deficient — check renal function + consider EPO supplementation.
The point: don't transfuse anemia of unclear etiology if there's time to diagnose + treat the cause.

Iron + EPO replacement protocols
IV iron preferred when ≥4 weeks until surgery + iron deficiency confirmed: ferric carboxymaltose 750-1000 mg single dose, or iron sucrose 200 mg q-other-day × 5 doses, or ferumoxytol.
Erythropoietin 600 IU/kg SC weekly × 3-4 doses, starting 3-4 weeks pre-op, raises Hb 1-2 g/dL — particularly valuable in CKD, anemia of chronic disease, refusal of transfusion (Jehovah's Witness).
Caution: EPO carries thrombotic risk; pair with prophylactic anticoagulation when appropriate.

PBM intraop pillar — blood conservation
Acute normovolemic hemodilution (ANH): remove 1-2 units of patient's whole blood at induction, replace with crystalloid/colloid, return blood at end.
Antifibrinolytics: tranexamic acid 1 g pre-incision + 1 g infusion or repeat dose — reduces transfusion 30-40% in major joint replacement (TXA in TKA/THA meta-analyses), 30% in cardiac surgery (BART comparator), 1.5 g loading + 1 g/8 hr in trauma (CRASH-2).
Topical hemostatics, controlled hypotension where safe, meticulous surgical technique.

Restrictive transfusion threshold
7 g/dL in stable patients (including critically ill, GI bleed, septic shock).Hb <8 g/dL threshold in cardiac patients + cardiac surgery (TRICS-III 2017 showed non-inferiority of restrictive strategy in cardiac surgery).
Symptoms (active ischemia, ongoing bleeding, hemodynamic instability) trump the number.
Single-unit transfusion practice: give 1 unit, reassess Hb + symptoms before a second.
No 'cross-match insurance' transfusion.

Jehovah's Witness perioperative plan
Individual variation in what is accepted — verify with patient pre-op + document specifically: cell salvage in continuous circuit (most accept), erythropoietin (most accept), iron (universal), albumin (most), FFP/cryo/platelets as fractions (variable — many accept), factor concentrates (most accept), hemoglobin-based oxygen carriers (case-by-case).
Get a signed JW-specific consent identifying each product class accepted or refused.
Multidisciplinary planning meeting with surgeon, anesthesia, hematology.
Optimize preop Hb aggressively (target >13 elective).
Intraop: cell salvage + ANH (closed circuit) + TXA + meticulous hemostasis + controlled hypotension when safe + smaller incisions when possible.
Consider delaying elective surgery weeks for anemia optimization.
Pediatric JW patients: court orders in life-threatening situations may override parental refusal (consult hospital ethics/legal early).

End of lecture
You just covered ~3 minutes of Pre-anesthesia. Reinforce with a few questions while it's fresh.